Affymetrix Q3 Revenues, Income Rise | GenomeWeb

NEW YORK, Oct. 22 (GenomeWeb News) - Affymetrix reported revenues of $76.2 million for the third quarter today, up from $ 72.7 million for the same period last year.

These revenues included $71.1 million in product revenue, compared to $62.9 million for the third quarter of 2002.

The company’s net income rose with revenues, to $5.8 million for the quarter, compared to $0.6 million for the same period last year. This is the third consecutive quarter of profitability for the Santa Clara, Calif. microarray company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.